GNH USA

Europe — EMA

Mycophenolate Mofetil Generics [uk]

GNH USA supplies Mycophenolate Mofetil Generics (Mycophenolate Mofetil), an immunosuppressant for rejection and lupus nephritis. Request a quote for supply.

Mycophenolate Mofetil

Request sourcing

1
Pack/s

What is Mycophenolate Mofetil?

Mycophenolate Mofetil, the active ingredient in Mycophenolate Mofetil Generics, is an immunosuppressant presented as an oral formulation for use in transplant and autoimmune disease patients. It helps prevent acute organ rejection and treats lupus nephritis.

GNH USA supplies Mycophenolate Mofetil Generics as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

What is Mycophenolate Mofetil used for?

Mycophenolate Mofetil is used in immunosuppressive therapy for conditions that involve organ transplantation or autoimmune kidney disease. - Kidney transplantation: prevents acute graft rejection - Heart transplantation: prevents acute graft rejection - Lupus nephritis: reduces renal disease activity

What are the side effects of Mycophenolate Mofetil?

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset - Diarrhea: frequent loose stools - Vomiting: occasional emesis - Abdominal pain: cramping or discomfort - Headache: transient mild pain - Upper respiratory infection: increased susceptibility

Serious or Rare Side Effects: - Leukopenia: significant drop in white blood cells - Anemia: reduced red blood cell count - Severe infections: opportunistic bacterial, viral or fungal infections - Hepatic dysfunction: elevated liver enzymes or hepatitis - Malignancy: increased risk of certain cancers - Progressive multifocal leukoencephalopathy: rare demyelinating disease

What precautions apply to Mycophenolate Mofetil?

Patients receiving Mycophenolate Mofetil require careful monitoring and counseling. - Monitor blood counts: regular CBC to detect leukopenia or anemia - Assess renal function: adjust dose in renal impairment - Screen for infections: watch for opportunistic infections - Avoid live vaccines: immunosuppression may reduce efficacy - Pregnancy: risk unknown, discuss with specialist - Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

What does Mycophenolate Mofetil interact with?

Mycophenolate Mofetil can interact with several medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption - Azathioprine: additive bone marrow suppression - Cyclosporine: increased mycophenolate exposure - Live vaccines: contraindicated due to immunosuppression

Moderate Interactions (Monitor Closely): - Rifampin: decreases mycophenolate levels - Warfarin: may alter INR monitoring - Inactivated vaccines: monitor immune response

Frequently asked questions

What conditions is Mycophenolate Mofetil used for?+
Mycophenolate Mofetil is prescribed to prevent acute rejection after organ transplantation, such as kidney, heart or liver transplants, and to treat lupus nephritis, an autoimmune kidney disorder. It works by suppressing the immune system to protect the transplanted organ or reduce kidney inflammation.
How does Mycophenolate Mofetil work in the body?+
After oral administration, Mycophenolate Mofetil is converted to mycophenolic acid, which blocks the enzyme inosine monophosphate dehydrogenase. This inhibition stops the synthesis of guanosine nucleotides needed for DNA replication in lymphocytes, thereby reducing the proliferation of T‑ and B‑cells and dampening immune responses.
What is the usual dose of Mycophenolate Mofetil?+
The dosage of Mycophenolate Mofetil is individualized by the prescribing clinician based on the specific transplant type, renal function, and patient tolerance. Only a qualified healthcare professional should determine the appropriate dose and schedule.
Is Mycophenolate Mofetil safe during pregnancy or breastfeeding?+
The safety of Mycophenolate Mofetil in pregnancy and lactation is not well established. It is generally classified as contraindicated in pregnancy because of potential fetal risk, and breastfeeding is not recommended. Patients should discuss alternatives with their specialist before conception or while nursing.
How do I order Mycophenolate Mofetil Generics from GNH USA?+
To request Mycophenolate Mofetil Generics, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Mycophenolate Mofetil compare with other immunosuppressants?+
Compared with calcineurin inhibitors such as cyclosporine or tacrolimus, Mycophenolate Mofetil offers a different mechanism—targeting nucleotide synthesis rather than calcineurin pathways. It is often used in combination regimens to provide synergistic immunosuppression while potentially reducing the dose‑related toxicity of each individual agent.
What are the recommended storage conditions for Mycophenolate Mofetil?+
Mycophenolate Mofetil should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain stability and potency.
How is Mycophenolate Mofetil administered?+
Mycophenolate Mofetil is taken orally, usually as tablets or capsules, with or without food as directed by the prescriber. The exact administration schedule—once, twice or three times daily—depends on the clinical protocol and patient-specific factors.
What are the most serious risks associated with Mycophenolate Mofetil?+
Serious risks include severe bone‑marrow suppression leading to leukopenia or anemia, opportunistic infections, hepatic injury, and an increased long‑term risk of certain malignancies. Patients should be monitored regularly for blood counts, liver function and signs of infection.
Who should not take Mycophenolate Mofetil?+
Mycophenolate Mofetil is contraindicated in patients with known hypersensitivity to the drug or its components, in those receiving live vaccines, and in pregnant women unless the benefits outweigh the risks. Individuals with severe hepatic impairment or uncontrolled infections should also avoid its use.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Mycophenolate Mofetil
Route
Oral Use
Manufacturer
Generics [uk] Limited
Origin
EU

Related products

CellCept 250 mg/1

CellCept 250 mg/1

Mycophenolate Mofetil · 250 mg

CellCept
CAPSULE
Genentech, Inc.
USA
CellCept 250 mg/1

CellCept 250 mg/1

Mycophenolate Mofetil · 250 mg

CellCept
CAPSULE
Genentech, Inc.
USA
CellCept 500 mg/1

CellCept 500 mg/1

Mycophenolate Mofetil · 500 mg

CellCept
TABLET, FILM COATED
Genentech, Inc.
USA
CellCept 500 mg/1

CellCept 500 mg/1

Mycophenolate Mofetil · 500 mg

CellCept
TABLET, FILM COATED
Genentech, Inc.
USA